WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fady Ibraham MalikEVP Research Development2025-07-082,000$33.76
$67.52kSell
Fady Ibraham MalikEVP Research Development2025-07-082,000$10.60
$21.20kBuy
Robert I. BlumPresident CEO2025-07-015,000$33.55
$167.75kSell
Fady Ibraham MalikEVP Research Development2025-06-172,000$32.91
$65.82kSell
Fady Ibraham MalikEVP Research Development2025-06-172,000$10.60
$21.20kBuy
Robert I. BlumPresident CEO2025-06-165,000$33.80
$169.00kSell
Edward M. Md KayeDirector2025-06-053,636$32.10
$116.72kSell
Andrew CallosEVP Chief Commercial Officer2025-06-058,659$32.04
$277.43kSell
Fady Ibraham MalikEVP Research Development2025-06-032,000$31.88
$63.76kSell
Fady Ibraham MalikEVP Research Development2025-06-032,000$10.60
$21.20kBuy

1 of 16

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc13.03%15,563,778$519.21MInstitution
Vanguard Group Inc9.92%11,849,547$395.30MInstitution
Fmr LLC8.64%10,316,131$344.15MInstitution
T Rowe Price Investment Management Inc8.34%9,955,251$332.11MInstitution
Michael Schmertzler8.15%9,730,131$324.60MInsider
Wellington Management Group LLP6.69%7,988,740$266.50MInstitution
State Street Corp5.10%6,085,001$203.00MInstitution
Deep Track Capital LP2.57%3,073,853$102.54MInstitution
Geode Capital Management LLC2.46%2,937,484$97.99MInstitution
Eastern Capital Ltd2.41%2,883,845$96.21MInsider

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK89.90%10.10%Net SellingNet Selling
KRYS78.32%21.68%Net Selling
RYTM87.51%12.49%Net SellingNet Selling
AKRO73.67%26.33%Net BuyingNet Selling
ADMA78.50%21.50%Net SellingNet Selling
View Top Biotech Stocks

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 113.39% institutional shareholders, 12.73% Cytokinetics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 8.15% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $333.26M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.